Radical dissection after positive groin sentinel biopsy in melanoma patients: Rate of further positive nodes

Melanoma Research

Volumn 19, Issue 2, 2009, Pages 112-118

  Santinami, Mario ^a,b   Carbone, Antonino ^b   Crippa, Federica ^a   Maurichi, Andrea ^a   Pellitteri, Cristina ^a   Ruggeri, Roberta ^a   Zoras, Odysseas ^c   Patuzzo, Roberto ^a  

^a Melanoma and Sarcoma Unit   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER PATIENT; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INGUINAL LYMPH NODE; LEG; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MACROMETASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; MICROMETASTASIS; PELVIS LYMPH NODE; PRIMARY TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; THICKNESS; TRUNK; TUMOR BIOPSY; INCIDENCE; INGUINAL REGION; KAPLAN MEIER METHOD; LYMPHEDEMA; METHODOLOGY; MIDDLE AGED; SCINTISCANNING;

COLORING AGENT; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

AGED; COLORING AGENTS; FEMALE; GROIN; HUMANS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; LYMPHEDEMA; MALE; MELANOMA; MIDDLE AGED; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY;

EID: 65449131669     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/CMR.0b013e328329fe7d     Document Type: Article

References (20)

1. Lloyd A, Mack J, Mack GM, McKinnon M. Controversies in the management of metastatic melanoma to regional lymphatic basins. J Surg Oncol 2004; 86 :189-199.
2. Essner R, Scheri R, Kavanagh M, Torisu-Itakura H, Wanek LA, Morton DL. Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection. Arch Surg 2006; 141:877-884.
3. Wong SL, Donald L, Morton John F, Jeffrey FE, Stanley GP, Leong L, et al. Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study. Ann of Surg Onc 2006; 13:809-816.
4. Kettlewell S, Moyes C, Bray C, Soutar D, MacKay A, Byrne D, et al. Value of sentinel node status as a prognostic factor in melanoma: prospective observational study. BMJ 2006; 332:1423.
5. Van Akkooi AC, de Wilt JH, Verhoef C, Schmitz PIM, van Geel AN, Eggermont AM, Kliffen M. Clinical relevance of melanoma micrometastases ( < 0.1 mm) in sentinel nodes: Are these nodes to be considered negative? Ann Oncol 2006; 17:1578-1585.
6. Lee JH, Essner R, Torisu-Itakura H, Wanek L, Wang H, Morton DL. Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma. J Clin Oncol 2004; 22 :3677-3684.
7. Gershenwald JE, Thompson W, Mansfield PF, Lee JE, Colome MI, Tseng C-H, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999; 17:976-983.
8. Carlson GW, Murray DR, Lyles RH, Staley CA, Hestley A, Cohen C. The amount of metastatic melanoma in a sentinel lymph node: does it have prognostic significance? Ann Surg Oncol 2003; 10:575-581.
9. Essner R. The role of lymphoscintigraphy and sentinel node mappng in assessing risk in melanoma. Semin Oncol 1997; 24:54-60.
10. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127:392-399.
11. Karimipour DJ, Lowe L, Su L, Hamilton T, Sondak V, Johnson TM, Fullen D. Standard immunostains for melanoma in sentinel lymph node specimens: which ones are most useful? J Am Acad Dermatol 2004; 50:759-764.
12. Starz H. Pathology of the sentinel lymph node in melanoma. Semin Oncol 2004; 31:357-362.
13. Dewar DJ, Newell B, Green MA, Topping AP, Powell BW, Cook MG. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol 2004; 22 :3345-3349.
14. Benoit L, Boichot C, Cheynel N, Arnould L, Chauffert B, Cruisenier J, Fraisse J. Preventing lymphedema and morbidity with an omentum flap after ilioinguinal lymph node dissection. Ann Surg Oncol 2005; 12:793-799.
15. Spratt J. Groin dissection. J Surg Oncol 2000; 73:243-262.
16. Ames FC, Singletary SE. Cutaneous malignancies of the trunk and lower extremities. In: Johnson DE, Ames FC, editors. Groin dissection. Chicago: Mosby-year book; 1985. pp. 111-137.
17. Bowsher WG, Taylor BA, Hughes LE. Morbidity, mortality and local recurrence following regional node dissection for melanoma. Br J Surg 1986; 73:906-908.
18. Karakousis CP. Therapeutic Node Dissections in malignant melanoma. Ann Surg Oncol 1998; 5:473-482.
19. Pearlman NW, McCarter MD, Frank M, Hurtubis C, Merkow RP, Franklin WA, et al. Size of sentinel node metastases predicts other nodal disease and survival in malignant melanoma. Am J Surg 2006; 192:878-881.
20. Henderson MA. Completion lymphadenectomy for melanoma patients with a positive sentinel node biopsy remains a standard of care. Ann Surg Oncol 2006; 13:761-763.